Attached files

                                   EXHIBIT 32





     In connection with the quarterly report of Biocurex,  Inc., (the "Company")
on Form 10-Q for the quarter  ended March 31, 2011 as filed with the  Securities
and Exchange Commission (the "Report") Dr. Ricardo Moro, the Principal Executive
Officer of the Company and Gladys Chan, the Principal  Financial  Officer of the
Company, certify pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and results of operation of
          the company.


May 12, 2011                          By /s/ Ricardo Moro
                                         ------------------------------------
                                         Dr. Ricardo Moro - President, Chief
                                         Executive Officer


                                      By:/s/ Gladys Chan
                                         -----------------------------------
                                         Gladys Chan - Principal Financial
                                         Office